Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 EUR | -0.98% | -1.46% | +7.16% |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Feb. 14 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 46
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Tests, Analysis Systems, and Products
100.0
%
| 11 | 100.0 % | 13 | 100.0 % | +19.40% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe, Other
43.6
%
| 5 | 41.9 % | 6 | 43.6 % | +24.16% |
Asia
34.9
%
| 5 | 43.2 % | 5 | 34.9 % | -3.51% |
Other Countries
17.4
%
| 1 | 10.2 % | 2 | 17.4 % | +103.03% |
North and South America
2.5
%
| 0 | 2.5 % | 0 | 2.5 % | +18.25% |
Finland
1.6
%
| 0 | 2.1 % | 0 | 1.6 % | -10.21% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jussi Hahtela
CEO | Chief Executive Officer | 51 | 21-06-03 |
Jussi Sorvo
DFI | Director of Finance/CFO | 34 | 20-12-31 |
Panu Hendolin
CTO | Chief Tech/Sci/R&D Officer | 53 | 21-12-31 |
Kalle Härkönen
BRD | Director/Board Member | 56 | 19-12-31 |
Graham Johnson
SAM | Sales & Marketing | - | Nov. 21 |
General Counsel | 37 | 13-12-31 | |
Ilari Patrakka
PRN | Corporate Officer/Principal | 44 | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 23-06-13 | |
Founder | 81 | 87-12-31 | |
Director/Board Member | 73 | 19-04-23 | |
Kalle Härkönen
BRD | Director/Board Member | 56 | 19-12-31 |
Franco Aiolfi
BRD | Director/Board Member | 77 | 13-04-07 |
Feng Liu
BRD | Director/Board Member | 52 | 18-08-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 20 | 2,975,500 | 0 | 0 | 42.47 % |
Stock B | 1 | 12,198,093 | 6,444,275 ( 52.83 %) | 0 |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.16% | 32.95M | |
+5.28% | 7.91B | |
-11.65% | 2.74B | |
+2.91% | 2.11B | |
-30.72% | 1.06B | |
-19.08% | 733M | |
-9.54% | 805M | |
-58.27% | 652M | |
-29.34% | 669M | |
-26.01% | 672M |
- Stock Market
- Equities
- BIOBV Stock
- Company Biohit Oyj